Joon Young Hur

8PUBLICATIONS
38CO-AUTHORS
Medical infection agents (incl. prions)Predictive and prognostic markersImmunogenetics (incl. genetic immunology)Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 22, 2026
Distinct clinical and genetic characteristics of myelodysplastic syndrome in younger patients.

|May 06, 2026
Histology-defined activated cancer-associated fibroblasts are associated with poor survival in diffuse-type gastric adenocarcinoma.

|Feb 24, 2026
The surgery for the patients with intestinal non‑Hodgkin lymphomas: a nationwide study.

Jiyeong Kim, Jun Ho Lee, Sung Hwan Hwang

|Sep 30, 2024
p27 Cell Cycle Inhibitor and Survival in Luminal-Type Breast Cancer: Gene Ontology, Machine Learning, and Drug Screening Analysis.

In Ah Park, Yung-Kyun Noh, Kyueng-Whan Min

|Apr 19, 2024
CLDN18: Clinical, Pathological, and Genetic Signatures with Drug Screening in Gastric Adenocarcinoma.

Joon Young Hur, Kyueng-Whan Min, Yung-Kyun Noh

|Jan 11, 2021
Immunological Characteristics of Hyperprogressive Disease in Patients with Non-small Cell Lung Cancer Treated with Anti-PD-1/PD-L1 Abs.

Kyung Hwan Kim, Joon Young Hur, Jiae Koh

Pageof 2

Frequent Collaborators

2 joint publications

Minsuk Kwon

2 joint publications

Byoung Kwan Son

2 joint publications

Dong-Hoon Kim

2 joint publications

Mi Jung Kwon